OPINION
I. Introduction
Defendant filed a Motion for Partial Summary Judgment alleging that 28 U.S.C. § 1498(c) barred Plaintiff from receiving reasonable compensation under 28 U.S.C. § 1498(a) for infringement of Plaintiffs U.S. Patent No. Re. 34,162 (hereinafter, “Re. ’162 Patent”). The Re. ’162 patent teaches a process for making a silicon fiber sheet product used in the production of F-22 fighter planes. Because the fibers that form the sheet product are manufactured in a foreign country, and the manufacturing of the fibers is part of the patented process, this Court agreed with Defendant and held in its opinion of March 14, 2002, that Plaintiffs suit was barred by § 1498(c), because it was based on a “claim arising in a foreign country.” Zol-tek v. United States,
Nevertheless, the Court stayed Defendant’s motion, pending additional briefing by the parties on several issues that arose out of the Court’s holding regarding the effect of § 1498(c). The thrust of these issues was whether Plaintiff had a cause of action outside of § 1498 for a taking of its patent rights under the Fifth Amendment to the U.S. Constitution, over which this Court has jurisdiction by virtue of the Tucker Act.
II. Background
The background of this matter is set forth in the Court’s March 14, 2002 opinion, but a brief recitation of the relevant facts follows. Zoltek Corporation (“Zoltek” or “Plaintiff’) is the owner of the Re. T62 patent.
It is undisputed that Defendant contracted with Lockheed Martin Corporation (hereinaf
Defendant argued in its motion for partial summary judgment that Plaintiff was not able to assert a claim for reasonable compensation under § 1498(a) because both the Ni-ealon and Tyranno fibers are manufactured in a foreign country and, thus, any claim based on the manufacture of the sheet products arises in a foreign country. Defendant contended that pursuant to 28 U.S.C. § 1498, the government’s use of the accused process must arise in the United States and that “[s]ince the formation of the fiber from its precursor occurs outside the United States, the process is not ‘used’ in this country.” Def.’s Mot. Par. Summ. J. at 7. According to § 1498(c), the reasonable compensation described in § 1498(a) is not paid when the claim is one “arising in a foreign country.”
The Court’s March 14, 2002 ruling on Defendant’s motion for partial summary judgment agreed with Defendant in part. After a review of the statutory text and its legislative history, this Court found that 28 U.S.C. § 1498 does not apply to all forms of direct infringement as currently defined in 35 U.S.C. § 271. Zoltek Corp.,
Hence, the Court’s interpretation of § 1498 leaves Zoltek in a rather curious position. Although Zoltek possesses an exclusive property right in its patented process, both parties concede that under the Court’s interpretation Zoltek has no ability to enforce its right against the United States or its contractor, Lockheed Martin.
The Court ordered supplemental briefings on whether the alleged patent infringement in this case constitutes a Fifth Amendment taking and, if the alleged patent infringement does indeed constitute a Fifth Amendment taking, whether the Court’s interpretation of 28 U.S.C. § 1498(c) violates the Fifth Amendment. Zoltek Corp.,
Following oral argument, the Court asked the parties to file simultaneous supplemental briefs on the impact of 19 U.S.C. § 1337(Z) on this case.
III. Arguments of Counsel
A. The Takings Issue
Plaintiff argues that the alleged infringement in the instant case constitutes a Fifth Amendment taking. First, Plaintiff reminds the Court that the Court of Appeals for the Federal Circuit has repeatedly said that patent infringement by the United States is premised on the theory of eminent domain. Plaintiffs Supplemental Brief (“Pl.’s Supp. Br.”) at 15 (citing Hughes Aircraft Co. v. United States,
Defendant strongly urges the Court to find that a Fifth Amendment takings analysis is not appropriate in this case. The government argues that the application of § 1498 to the present case does not constitute a “taking” of a property right under the Fifth Amendment. First, Defendant expresses its view that the essence of § 1498 is not patent infringement, rather it is a unique statute that “grants the government a license to use any and all patents, subject to the payment of ‘reasonable compensation.’ ” Def.’s Supp. Br. at 2. Second, Defendant argues that § 1498 is not an exercise of eminent domain, either. Rather, the government characterizes § 1498 as a provision granting a limited type of property right upon the patent owner, and argues that the Fifth Amendment is not violated by operation of § 1498 with respect to patents currently enforceable.
Defendant argues that if takings jurisprudence were relied upon nevertheless, then the standard set forth in Ruekelshaus v. Monsanto Co.,
Furthermore, Defendant argues that Plaintiff could not show that § 1498 interferes with reasonable investment-backed expectations, a factor relied upon by the Supreme Court in Monsanto. Since § 1498 was in existence at the time the patent was issued, Defendant concludes that Zoltek must have known the scope of its rights, and that the scope of recovery under § 1498 was not the same as that under Title 35. Moreover, the government argues that taking one right out of the bundle of rights does not automatically constitutes a taking. Def.’s Supp. Br. at 7.
Defendant concedes that the Supreme Court has held that patents are property capable of being appropriated (James v. Campbell,
Defendant maintains that since Richmond Screw Anchor, there have been no cases dealing directly with the constitutionality of § 1498 per se. Rather, the cases usually address what is “reasonable compensation,” and they should not be read to suggest that § 1498 has to be judged by Fifth Amendment standards. Moreover, Defendant believes that this Court should not consider the constitutional issue at all because Plaintiff has not proven that it is entitled to recovery under 35 U.S.C. § 271. Oral argument was held on this issue on September 19, 2002.
B. 19 U.S.C. § 1337(Z)
Plaintiff argues that after reading together the provisions of 35 U.S.C. § 271(g), 19 U.S.C. § 1337(Z), and 19 U.S.C. § 1337(a)(1), “it is clear that the United States is permitted to import articles using process steps which, if practiced in the United States, would result in the infringement of Zoltek’s Re. ’162 patent-in-suit if ‘reasonable and entire compensation’ is paid.” Pl.’s Second Supp. Br. at 4. Plaintiff further argues that under these provisions, the United States cannot use an article that would otherwise be excluded without paying reasonable and entire compensation for its use and manufacture. Plaintiff argues that the government’s interpretation of § 1498(e) is untenable because if Zoltek’s claims arise in a foreign country, it would then have no remedy under § 1498(a) or 1337(Z). Id.
Defendant argues that this Court does not have jurisdiction over claims arising under 1337(Z) unless action has been taken by the ITC. Def.’s Second Supp. Br. at 1, 3. Defendant argues that for this Court to act pursuant to § 1337(Z), it must have an Order from the ITC indicating that the article “would have been excluded [from entry] or would not have been entered” because the ITC has exclusive jurisdiction over the matter. Def.’s Second Supp. Br. at 3. Likewise, Defendant argues that the Court does not have jurisdiction to consider the second issue, whether the Court can award reasonable and entire compensation under § 1498(a), because there has been no action by the ITC. If such action were taken, Defendant speculates that it would be “permitted to present any defenses it may have.” Def.’s Second Supp. Br. at 8. Nonetheless, Defendant argues that no justi-
C. The Headquarters Claim Doctrine
Plaintiff has presented a lengthy argument urging this Court to apply the “headquarters claim” doctrine to this case, which essentially asks the Court to reconsider its March opinion on the appropriate interpretation of § 1498(c). PL’s Supp. Br. at 5-6. The headquarters claim doctrine is a body of case law applicable to the Federal Tort Claims Act (“FTCA”). 28 U.S.C. §§ 2671-2680. PL’s Supp. Br. at 3. Section 2680(k) of the FTCA provides that the Act shall not apply to “any claim arising in a foreign country,” which is the same language found at § 1498(c). Compare 28 U.S.C. § 1498(c) with 28 U.S.C. § 2680(k). Thus, Plaintiff rationalizes that the headquarters claim doctrine is applicable to this case.
Defendant disagrees. Although the identical language in these two sections should be interpreted consistently, Defendant argues that the headquarters claim doctrine is only relevant to the FTCA. The parties were heard on this issue during the September 19, 2002 oral argument.
IV. Discussion
A. Zoltek’s Remedy Under § 1337(Z)
The parties were asked to address whether the determination that an article “would have been excluded from entry or would not have been entered” can include consideration of 35 U.S.C. § 271(g). Furthermore, the parties were asked if the determination is made that an article “would have been excluded from entry or would not have been entered” because of 35 U.S.C. § 271(g), can the Court award reasonable and entire compensation under 28 U.S.C. § 1498(a). The parties’ attention was directed to the language of § 1337(Z), which states: “pursuant to the procedures of § 1498 of Title 28” (emphasis added). The Court found supplemental briefing on this issue was necessary because if Zoltek had an adequate remedy for the government’s alleged infringement under § 1337(Z), there would be no need for the Court to address the takings issue, which should be resorted to only if Zoltek has no other adequate remedy for the alleged infringement. Because the government stipulates that Zoltek has no remedy in this Court under § 1337(Z) or § 1498(c), the Court finds it appropriate to address the takings issue.
Section 1337(7) provides in relevant part:
Importation by or for United States — Any exclusion from entry or order under subsection (d), (e), (f), (g), or (i) of this section, in cases based on a proceeding involving a patent ... under subsection (a)(1) of this section, shall not apply to any articles imported by and for the use of the United States, or imported for, and to be used for, the United States with the authorization or consent of the Government. Whenever any article would have been excluded from entry or would not have been entered pursuant to the provisions of such subsections but for the operation of this subsection, an owner of the patent ... shall be entitled to reasonable and entire compensation in an action before the United States Court of Federal Claims pursuant to the procedures of section 1498 of Title 28.
19 U.S.C. § 1337(7). Defendant argues that this Court lacks jurisdiction to consider whether, in an action under § 1337(7) (a “ ’337 action”), the fiber products at issue in this case “would have been excluded from entry or would not have been entered” because that question is within the exclusive jurisdiction of the ITC, “subject to review of the President and the Federal Circuit.” Def.’s Second Supp. Br. at 4. Moreover, Defendant argues that the Court lacks jurisdiction because Zoltek has not alleged an injury under 1337(Z), the existence of an exclusion order, that goods have entered the United States despite an exclusion order, or that there has been an injury to its business from entry of such goods. Thus, according to the Defendant, there is no justiciable case or controversy. The government is correct. Zoltek does not assert in its brief that an exclusion order has been entered or other action has been taken by the Commission with respect to the fiber products at issue.
Furthermore, Defendant points out that a claim under § 1337 is not parallel to an action under § 1498(a). Defendant notes that the patent owner bringing a ’337 action must show, or the Commission must find, that “an industry in the United States, relating to the articles protected by the patent ... concerned, exists or is in the process of being established.” Def.’s Second Supp. Br. at 7 (quoting 19 U.S.C. § 1337(a)(2)). Section 1337(a)(3) provides that “an industry in the United States shall be considered to exist if there is in the United States ... (A) significant investment in plant and equipment; (B) significant employment of labor or capital; or (C) substantial investment in its exploitation ____” 19 U.S.C. § 1337(a)(3). Also, the Commission must consider the effect of the exclusion on consumers under § 1337(d), and ultimately the President can disapprove the ITC’s determination under § 1337(j). Def.’s Second Supp. Br. at 8. As Defendant’s argument suggests, these factors are unique to ’337 actions, and are not similarly part of a prima facie case of patent infringement under Title 35. These showings, which are required to support a successful ’337 action, are notoriously difficult and expensive to establish.
Defendant contends that “Congress also clearly intended that compensation due under § 1337(Z) was to be determined under the same principles as in § 1498 ... [a]nd the government is permitted to present any defenses it may have.” Def.’s Second Supp. Br. at 8. Nonetheless, as Defendant argues, the relationship between § 1498(a) and 1337(i) will not be decided in this opinion. Defendant stipulates that § 1337(0 is of no avail to Zoltek, and this provision “will not affect the outcome of this case.” Id. Thus, the Court will decide whether Zoltek can proceed with its claim under a takings theory.
B. The Takings Issue
As a threshold matter, Defendant’s argument that Plaintiffs constitutional claim is premature because Zoltek has not provided any facts that would allow it to recover under 35 U.S.C. § 271 is not persuasive. As a result of the Court’s decision of March 14, 2002, both parties concede that Zoltek has no remedy under § 1498 against the government or its contractor. Absent the Court’s finding that Zoltek may assert a takings claim on Fifth Amendment grounds, the Court would have to rule in Defendant’s favor, since it has met its burden and proven an affirmative defense under § 1498(c). Defendant has proffered evidence showing that both the allegedly infringing products, the Nicalon and Tyranno fibers, were manufactured abroad. Thus, the Court must decide whether to allow Plaintiff to proceed under the Tucker Act, 28 U.S.C. § 1491, which provides that Plaintiff may bring a claim for money damages against the United States if
1. Tucker Act Jurisdiction in Takings Claims
The Takings Clause of the Fifth Amendment provides that the government shall not take private property without compensating its owners. U.S. Const, amend. V (“[N]or shall private property be taken for public use, without just compensation.”). The Supreme Court has explained in United States v. Mitchell, that “the Tucker Act ‘does not create any substantive right enforceable against the United States for money damages.’ A substantive right must be found in some other source of law, such as ‘the Constitution ____’” United States v. Mitchell,
The Takings Clause is based on the rationale that the government may take private property for public use but, when it does, the government must pay for it. See First English Evangelical Lutheran Church of Glendale v. County of Los Angeles,
2. Patent Rights Are Property Rights Taken by Eminent Domain Pursuant to § 1498
The Federal Circuit, its predecessor court, the Court of Claims, and the U.S. Supreme Court have repeatedly recognized that patent rights are property rights. Furthermore, in the context of § 1498, the Federal Circuit and the Court of Claims have characterized the use of another’s patent rights by the United States, without the permission of the patent owner, as an exercise of eminent domain. In Leesona Corp. v. United States,
A property right in a patent is not a novel concept. By 1876 the law was well-settled that a patent owner enjoyed a property right
The Federal Circuit has acknowledged § 1498’s basis in eminent domain in several opinions
Many judges on the U.S. Court of Federal Claims have agreed with the analogy to eminent domain.
Leesona held that the award of treble damages, provided for in the Patent Act, was not available for § 1498 actions, because “the reasonable and entire compensation” phrase in § 1498 was “the just compensation required by the fifth amendment.” Leesona,
Judge Andewelt in De Graffenried, however, felt that the government had not “taken” anything of the plaintiffs by infringing its patent. He reasoned that the “metes and bounds” of a patent were delimited by the “statutory framework” at the time that the patent was granted. At the time that the plaintiff obtained his patent, the statutory framework included not only the Patent Act (specifically § 35 U.S.C. 154) but also § 1498, which, he held, subjects the patent to use by the government whether or not such use is licensed. Thus, as the government already has the right to use the patent, it does not “take” anything of the plaintiffs when it uses it. De Graffenried,
Consequently, whether the plaintiff was a “prevailing party” in an eminent domain proceeding was irrelevant. Judge Andewelt did not cite any authority for this reasoning, and his decision that the plaintiff was a prevailing party for purposes of EAJA could have been based more narrowly on two other grounds that he discussed, namely, (1) the difference between § 1498 proceedings and typical emi
Defendant in this case makes a similar argument-that the Re. T62 patent when granted was subject to a compulsory license in favor of the government by virtue of § 1498. Although this reasoning has a certain appeal-especially to get out of a “tight spot” involving a peripheral issue such as attorneys’ fees-it does not withstand close scrutiny. Moreover, it does not account for the numerous statements regarding eminent domain and § 1498 by the Court of Claims and the Federal Circuit.
The task of specifying the bundle of rights that a patent owner possesses naturally begins with the Patent Act. The plain language of § 154, for example, states that every patent must contain:
[A] grant ... of the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States, and, if the invention is a process, of the right to exclude others from using, offering for sale or selling throughout the United States, or importing into the United States, products made by that process, referring to the specification for the particulars thereof.
35 U.S.C. § 154(a)(1).
The ambit of these rights is further specified by § 271, which defines what acts constitute patent infringements.
That a wrongful act was a component of the 1910 predecessor to § 1498 was the view of the U.S. Supreme Court in Crozier v. Fried, Krupp Aktiengesellschaft,
Aside from the language of § 1498, there are logical and policy problems with the De Graffenried analysis. If, “when the government uses a patented invention, it does not ‘take’ any property interest that belongs to the patent owner” because “the government cannot ‘take’ what it already possesses,” De Graffenried,
The policy problem caused by the De Graf-fenried analysis is that, taken to its logical extreme, the government can avoid paying for any use of a patent by always defining the property right in a patent to exclude use by the government. Indeed, this stratagem could be applied against any property right the federal government has the power to create. This concept is not as far-fetched as it may sound. As the U.S. Supreme Court in James pointed out: “the sovereigns of England ... can reserve to itself [sic ], either expressly or by implication, a superior dominion and use in that which it grants by letters-patent----”
3. Patent Rights Taken by Eminent Domain outside of § 1498
Having established that patent rights are property that may be taken by eminent domain pursuant to § 1498, the Court now turns to the question of whether the government may be said to “take” patent rights that are not mentioned in § 1498. If the answer is in the affirmative, another question arises: What was the purpose of enacting § 1498? In other words, if the Fifth Amendment requires compensation every time that the federal government exercises a patent right without the permission of the patent owner and if the predecessor court of the U.S. Court of Federal Claims (the Court of Claims) had jurisdiction over Fifth Amendment takings claims from 1887 through the Tucker Act, it would seem that § 1498 was unnecessary. After examining the history of the evolution of § 1498, the Court concludes that indeed § 1498 is now unnecessary to secure for a patent owner the right to recover for unauthorized use and manufacture by the U.S., as patent infringement by the U.S. government is now clearly recognized as a taking and as the Tucker Act provides the U.S. Court of Federal Claims with jurisdiction to hear takings claims.
But this was not so in 1910 when the predecessor of § 1498 was enacted.
The legislative history of the 1910 Act makes clear that its purpose was to confer on the Court of Claims jurisdiction to hear patent infringement suits against the federal government, because the U.S. Supreme Court in Schillinger had held that patent infringements were torts. See H.R. Comm. Rep. No. 61-1288, at 1, 3 (1910). Then as now, the Tucker Act expressly withheld from the Court of Claims jurisdiction for cases sounding in tort. Schillinger,
In very strong terms, Justice Harlan dissented, arguing that the use of the invention was a taking, either based on implied contract or based upon the constitution, both of which were the kinds of cases that the Court of Claims was empowered to hear under the Tucker Act. Id. at 173-180,
If the Schillinger patent be valid, and if the invention described in it has been used or appropriated by the government through its agent charged with the improvement of the capítol grounds, then the patentee, or those entitled to enjoy the exclusive rights granted by it, are entitled to be compensated by the government. And the claim to have just compensation for such an appropriation of private property to the public use is “founded upon the constitution of the United States.” It is none the less a claim of that character even if the appropriation had its origin in tort. The constitutional obligation cannot be evaded by showing that the original appropriation was without the express direction of the government, nor by simply interposing a denial of the title of the claimant to the property or property rights alleged to have been appropriated. The questions of title and appropriation are for judicial determi*702 nation. Those being decided in favor of the claimant, the constitution requires a judgment in his favor. If the claim here made to be compensated for the use of a patented invention is not founded upon the constitution of the United States, it would be difficult to imagine one that would be of that character.
Schillinger,
After the 1910 Act was passed — conferring jurisdiction on the Court of Claims for patent infringement suits against the U.S. — the U.S. Supreme Court in Crozier construed the 1910 Act as following the Harlan theory.
[W]e think there is no room for doubt that [the 1910 Act] makes full and adequate provision for the exercise of the power of eminent domain for which, considered in its final analysis, it was the purpose of the statute to provide.
Id. at 307,
Thus, Crozier effectively overruled Schil-linger sub silentio and reinstated the theory of James v. Campbell “[t]hat the government of the United States when it grants letters-patent for a new invention or discovery in the arts, confers upon the patentee an exclusive property in the patented invention which cannot be appropriated or used by the government itself, without just compensation, any more than it can appropriate or use without compensation land which has been patented to a private purchaser, we have no doubt.”
4. Reconciling § 1498 and the Patent Act
As the evolution of the law regarding patent infringement suits against the government shows, Congress and the Supreme Court now see acts of the U.S. government that between private parties would be patent infringement as eminent domain takings; thus, § 1498 is-today-unnecessary, because all such acts would be encompassed in the Tucker Act jurisdiction of the now U.S.
In the case at bar, this task is not too difficult as the statutes are not in conflict, except by negative implication: “when two statutes are capable of co-existence, it is the duty of the courts, absent a clearly expressed congressional intention to the contrary, to regard each as effective.” Morton v. Man-can,
But does § 1498 limit the Court’s jurisdiction under the Tucker Act by negative implication to just the patent infringements delimited in § 1498? Normally, the argument for limitation by negative implication would be articulated in this way: Does the fact that the 1910 Act only gave limited jurisdiction over patent infringements to the then Court of Claims mean that it withdrew the broader jurisdiction that it had under the Tucker Act? Although the scope of § 1498 is more narrow than the Tucker Act and although § 1498 was enacted after the Tucker Act, this Court is not convinced that, in enacting the predecessor of § 1498, Congress intended to so limit the Tucker Act. First, before the passage of the 1910 Act, the state of the law was that the Tucker Act did not grant the Court of Claims any jurisdiction over patent infringements. Therefore, the usual articulation of the argument from negative implication does not apply. Second, The very purpose of the 1910 Act was to clarify that the then Court of Claims had jurisdiction over patent infringements by the U.S. as takings through eminent domain, as attested by numerous opinions from the U.S. Supreme Court and the Federal Circuit.
Therefore, there is no conflict in this case between the Tucker Act and § 1498. As there is no conflict, this Court has jurisdiction under the Tucker Act to hear an argument from the Plaintiff that the U.S. has taken other patent rights that belong to it, for example, the right to exclude others from importing and using products made abroad from its patented process.
Note, however, that while this Court is able to look outside of § 1498 to examine if patent rights have been taken, this does not imply that this Court is free to ignore § 1498 for all other provisions, such as calculation of damages. The measure of damages that is due from the government for a taking has always been just compensation. Finding a taking of rights outside of § 1498 does not entitle the Plaintiff to remedies under other sections of the Patent Act, such as the ability to recover treble damages. See, Leesona Corp.,
5. Can the government’s actions be considered a taking?
Early Supreme Court cases addressing the Takings Clause were decided when “it was generally thought that the Takings Clause reached only a ‘direct appropriation’ of property.” See Lucas v. South Carolina Coastal Council,
Justice Holmes recognized in Mahon, however, that if the protection against physical appropriations of private property was to be meaningfully enforced, the government’s power to redefine the range of interests included in the ownership of property was necessarily constrained by constitutional limits ____ These considerations gave birth in that case to the oft-cited maxim that, “while property may be regulated to a certain extent, if regulation goes too far it will be recognized as a taking.”
Today, there are at least two categories of takings where just compensation is due: (1) a physical occupation of the property at issue, the traditional idea of a taking; and (2) a regulatory taking. Regulatory takings are governed by the legal standards outlined in Monsanto.
In Monsanto, the Supreme Court held that the appropriation of an intellectual property interest by a government action requires just compensation for its use when a federal law deprives the intellectual property owner of virtually all investment-backed expectations in the intellectual property.
Although the Supreme Court held in Monsanto that an intellectual property right is entitled to Fifth Amendment protection, the government overlooks the importance of this holding to the case sub judice. In attempting to distinguish Monsanto, the government focuses on the termination of rights given to a party by statute, but seems to slight the crux of the case, namely that the law effected a taking when it changed Monsanto’s investment-backed expectations with respect to its interest in the intellectual property. The government’s explanation for why a taking actually occurred does not subtract from the Supreme Court’s acknowledgment that an appropriation of an intellectual property right is subject to analysis under the Court’s takings jurisprudence. Furthermore, the Court found that a Tucker Act remedy was available in that case because Congress had not unambiguously “withdrawn the Tucker Act grant of jurisdiction to the Court of Claims to hear the suit involving the statute [FIFRA] founded ... upon the Constitution.” Monsanto,
The government argues that the two enumerated types of takings are the only two “mutually exclusive” types of takings recognized by Fifth Amendment takings jurisprudence, Def.’s Supp. Br. at 3. This is incorrect. Courts have found compensable takings that do not fit neatly into one of these two categories. See, e.g., Shelden v. United States,
The government further contends that because Zoltek cannot claim physical invasion of its property, a regulatory taking is asserted. Def.’s Supp. Brief at 3. Zoltek offers little to persuade the Court otherwise. Plaintiff says the government’s alleged use of its process patent is not really a regulatory taking, but could not tell the court what type of taking it is. Tr. at 37. Herein lies the problem. For a taking to occur, the government must take existing property rights. These rights must be definable and ascertainable, and must be traceable to a particular source. For Zoltek to properly allege a taking, it must show a source of rights that exist outside of § 1498. The most likely source for existing rights that the government can be alleged to have taken in this action are other sections of the Patent Act, such as § 154 or § 271(g). Plaintiff, however, has not alleged in its complaint (original or amended) that a taking has occurred outside of § 1498 or, if such a taking has occurred, what sort of a taking it should be considered-i.e., whether such a taking is more analogous to an occupation of real property or more like the sort of regulatory taking identified in Monsanto. Alternatively, as Monsanto does not preclude the recognition of other forms of takings, Plaintiff could allege a taking of a different sort from either of these two categories. For example, it may be that-following the pattern of § 1498-once the government has been determined to have exercised a patent right, then a reasonable royalty is payable without engaging in a separate “taking” analysis.
C. The Federal Tort Claims Act
Plaintiff has presented a lengthy argument urging this Court to apply the “headquarters claim” doctrine to the issues presented in this case. The headquarters doctrine “holds that a tort claim arises in the United States if it is found that the United States is the proximate cause of the tort, regardless of where the injury actually took place.” Pl.’s Supp. Br. at 3. The headquarters claim doctrine is a body of ease law interpreting provisions of the Federal Tort Claims Act (“FTCA”). Section 2680(k) provides that the FTCA shall not apply to “any claim arising in a foreign country,” the same language used in § 1498(c). Plaintiff argues that “[i]t is a settled principle of statutory construction that, unless a contrary purpose is shown, it is presumed that statutory terms carry the same meaning when they appear in different sections of the same statute.” Pl.’s Supp. Br. at 3.
Defendant does not dispute this principle of construction. Def.’s Supp. Br. at 30; Tr. at 8. However, Defendant argues that the Court should not apply the headquarters claim doctrine to the case at bar because it ignores precedent and expands the government’s limited waiver of sovereign immunity. Def.’s Supp. Br. at 23-24.
Defendant argues persuasively that the headquarters doctrine has nothing to do with the interpretation of “arising in a foreign country.” Rather, it “is a corollary to the statutory requirement [28 U.S.C. § 1346(b)] to apply the law of the place where the negligence or willful acts or omissions occurred.” Def.’s Supp. Br. at 24. Defendant points out § 1346(b) is a choice-of-law provision and correctly states that 1498(c) does not contain similar language because, Defendant argues, patent law is federal and uniform and this choice-of-law inquiry is inapplicable to patent law cases. Defendant contends that the Court’s adoption of Plaintiffs argument would cause it to “inferentially includ[e]” the provisions of § 1346(b) into § 1498, which it argues is an unintended consequence. Def.’s Supp. Br. at 30.
The Court will not reconsider its interpretation of “arising” as Plaintiff asks it to do, and furthermore, the Court finds that the headquarters claim doctrine is not applicable to this case. The Court agrees with Defendant. It should interpret § 1498(e) and 2680(k) consistently because the rationale was the same in both statutes: “avoidance of unintended results and the desire to limit the application of the law to the territorial limits of the United States.” Def.’s Supp. Br. at 30.
The United States Court of Federal Claims has recognized that “the Supreme
The Court concurs with Judge Turner’s analysis, which is consistent with this Court’s interpretation of 1498(c). The Court’s interpretation of § 1498 in Hughes reinforces the notion that § 1498(c) was intended by Congress to have the same meaning as the language “within the United States” as found in 35 U.S.C. § 271(a).
Hence, the headquarters claim rationale is inapplicable to the instant case. The Court can interpret “arising in a foreign country” consistently without incorporating a doctrine applicable specifically to the FTCA.
Y. Conclusion
For the reasons stated above, Defendant’s Motion for Partial Summary Judgment is DENIED. Plaintiff is granted leave to amend its complaint in light of this ruling. If Plaintiff chooses to do so, it has 14 days to amend its complaint to allege a taking of its patent rights by the government outside of § 1498. The amended complaint should specify the source of the patent rights allegedly taken. The parties are ORDERED to file, within 14 days after Plaintiff files its amended complaint, a joint status report as to future proceedings in this case and to include three mutually agreeable dates, and an agreeable time during each date for a status conference. At the status conference, the parties shall be prepared to discuss what rights have allegedly been taken and how the Court should determine whether a taking has occurred.
This matter is subject to a Protective Order. The opinion shall be filed under seal until the parties review the opinion to see if any information should be redacted prior to publication in accordance with the terms of the protective order. The parties shall file a joint report indicating any such information that should be redacted within 10 days of the filing of this opinion.
Notes
. The Act of March 3, 1887, 24 Stat. 505, added the following to the then-Court of Claims's jurisdiction: "All claims founded upon the Constitution of the United States ... in cases not sounding in tort____” See Schillinger v. United States,
. Patent Re. '162 is a reissued patent. The original patent was filed on March 1, 1988 as U.S. Patent No. 4,728, 395 (" '395"). Zoltek sought reissue of Patent '395 on February 20, 1990 and on January 19, 1993, the Patent & Trademark Office ("PTO”) issued Re. '162. This Court rendered an opinion on Defendant’s Motion for Partial Summary Judgment regarding Re. '162 and ruled in part in favor of Plaintiff, holding that the claims of the Re. T62 patent were valid and dated back to the original date of filing of the '395 patent. See Zoltek v. United States, No. 96-166, slip op. at 1 (Fed.Cl. Sept. 13, 1999).
. The Re. T62 patent has 40 claims, some written in method form and others in product-by-process form. Zoltek is enforcing only the process claims of Re. '162 patent. Claims 1-22 and 33-38 are the method or process claims at issue in the government’s motion for partial summary judgment. Claims 1, 11, 15 and 33 are independent claims. Together these claims provide a method of manufacturing controlled surface electrical resistivity carbon fiber sheet products by, inter alia, partially carbonizing previously oxidized and stabilized fiber at an elevated temperature in an oxygen free environment. Re. '162 Pat., col. 1, 11. 64-68; col. 2, 11. 1-4, 42-50. Re. '162 Pat., col. 2, 11. 1-4. The final product is an end sheet product having the form of "paper, woven fabric and the like.” Re. '162 Pat., col. 2, 11. 57-60.
. Because § 1498(c) is worded negatively — indicating when § 1498(a) does not apply, rather than indicating the instances where § 1498(a) does apply — the Court explained in its March 14, 2002 opinion that Congress has signaled that § 1498(c) should be construed as an affirmative defense for the government, rather than an essential element to a plaintiff’s case under § 1498(a). Zoltek Corp.,
. The precursor to § 1498, the 1910 Act, was amended in 1918 to give government contractors immunity from suit in private litigation brought by the patent owner. Congress thought it necessary to shield government contractors from defending patent infringement actions, so as to encourage these contractors to undertake work that would aid the war effort. See Richmond Screw Anchor Co. v. United States,
. Two sections of the Patent Act are of particular relevance: § 154 and § 271(g). Section 154 grants the owner of a process patent “the right to exclude others from using, offering for sale, or selling throughout the United States, or importing into the United States, products made by that process.” Section 271(g) states that ”[w]hoever without authority imports into the United States or offers to sell, sells, or uses within the United
. 19 U.S.C. § 1337 allows a party, in a " ’337” action, to prevent a product made overseas from being imported into the United States if it competes with a product or process patented in the United States. If the imported product is determined to infringe by the United States Court of International Trade, then the International Trade Commission (“ITC” or “Commission”) may take action that will prevent the article from entering the United States. For example, the Commission may issue orders excluding the infringing article from entry into the United States, or order the infringing activity to cease and desist. 19 U.S.C. § 1337(d) and (f). However, 19 U.S.C. § 1337 (Z) prevents the ITC from ordering such an exclusion when the product is to be used by or for the United States with its authorization and consent. Instead, § 1337(Z) directs the party bringing the '337 action to sue the United States for "reasonable and entire compensation” according to the "procedures" set forth in 28 U.S.C. § 1498. 19 U.S.C. § 1337(Z).
. In Porter, the United States Court of Claims actually held for the defendant on the takings issue because the PlaintiE could not show that the United States "carried out the alleged taking of property” because the officials responsible for the alleged appropriation had no authority to act on behalf of the United States. Porter,
. Langenegger concerned the United States’ involvement with the planning, implementation and financing of a Salvadoran agrarian reform program which caused the government of El Salvador to confiscate the property of some U.S. citizens, who then alleged that the United States' involvement rose to the level of a taking under the Fifth Amendment. Langenegger,
. All reference to "transcript" ("Tr.”) herein refer to the September 19, 2002, Oral Argument Transcript, unless otherwise noted.
. The 1988 Process Patent Amendment Act of 1988, Pub.L. No. 100-418, § 9006(a), 102 Stat. 1107, 1567 (1988), was enacted in part because of the inadequacy of a '337 action. In particular, Congress recognized the limited remedies available to a patent owner in a '337 action for the use of a process patent outside the Unites States. See S.Rep. No. 100-83, 100th Cong., 1st Sess., at 30 (1987); H.R.Rep. No. 100-60, 100th Cong., 1st Sess., at 5 (1987).
. Hughes Aircraft Co. v. United States,
. See, e.g., Decca Ltd.,
. See e.g., Leesona Corp.,
. DowChem. Co. v. United States,
. This Court disagrees with Judge Andewelt’s characterization of these statements as dicta. De Graffenried,
. Because a patent owner's property rights under the applicable statutory scheme do not include the right to exclude the government from using his or her patented invention, when the government uses a patented invention, it does not "take” any property interest that belongs to the patent owner. Stated in another way, the government does not have to resort to exercising its sovereign power of eminent domain to utilize a patent owner’s patented invention because the statutory framework that defines a patent owner's property rights gives the government the authority to use all patented inventions. Thus, the government cannot “take” what it already possesses.
De Graffenried,
. De Graffenried has also been criticized by commentators as well. See Lavenue, supra n. 12 at 471-72 (“Although the Court of Federal Claims makes persuasive arguments in De Graf-fenried, this author considers the ultimate finding in error.”).
. Note that the prohibitions regarding use, sale, and importation of a product made overseas by a process patented in the U.S. is mentioned both in § 154 and § 271.
. The 1910 Act, for purposes of this discussion, was essentially the same as § 1498:
[Wjhenever an invention described in and covered by a patent of the United States shall hereafter be used by the United States without license of the owner thereof or lawful right to use the same, such owner may recover reasonable compensation for such use by suit in the court of claims. Pub.L. No. 61-305, 36 Stat. 851.
. The Court held that the statute
confers upon the patentee [the power] to seek redress in the court of claims for any injury which he asserts may have been inflicted upon him by the unwarranted use of his patented invention ____ The adoption by the United States of the wrongful act of an officer is, of course, an adoption of the act when and as committed, and causes such act of the officer to be, in virtue of the statute, a rightful appropriation by the government, for which compensation is provided. Crozier,224 U.S. at 305 ,32 S.Ct. 488 .
. Section 1498 has not changed significantly since 1910 for purposes relevant to this discussion. In 1918, the 1910 statute was amended to provide that a patent owner could not sue a government contractor; the patent owner’s ex-elusive remedy was against the U.S. ''Manufacture" and use “by or for" the U.S. were also added in 1918. The statute, originally in Title 35, was moved to Title 28 during the 1948 revision of Title 28.
. "Whatever ambiguity there may have been in the 1910 Act itself, the Supreme Court in Crozier v. Krupp clearly construed it as following the Harlan theory.” Leesona,
. The Defendant reads Crozier in light of De Graffenried, arguing that the 1910 Act gave a remedy to enforce the rights of patents in force at the time of its enactment, but that for patents issued after the enactment of the Act, the Act serves as a limitation of the scope of the patent right. That is to say, as in De Graffenried, the 1910 Act actually defines the patent vis-a-vis the federal government. Thus, Defendant argues that reliance on Crozier for the proposition that § 1498 implicates the government's use of eminent domain is only partly correct. For patents in force at the date of enactment, unauthorized use by the government is a taking by eminent domain; for patents issued thereafter, the government is merely exercising its reserved rights. Def.’s Supp. Br. at 13. This convoluted argument seems to be a desperate attempt to avoid the clear language of Crozier. In a very detailed analysis of the 1910 Act, and the amendments thereto, the Court of Claims recognized Crozier’s view that the 1910 Act was essentially an exercise of the government's power of eminent domain. Leesona Corp.,
. It should be noted that when the 1910 Act was passed, the Patent Act guaranteed patent owners "the exclusive right to make, use, and vend the invention.” In an era of extremely small and limited government by today's standards, it is quite possible that the drafters of the 1910 Act did not conceive that patent owners would have to be concerned that the U.S. would ever "make" or “vend” their patented items. Furthermore, at that time, prior to the 1918 Act, government contractors were still liable for suit for patent infringement done on behalf of the U.S. Therefore, it seems likely that the terms “make” and "vend” were excluded from the 1910 Act as irrelevant.
. It should be noted that one of the few cases prior to Pennsylvania Coal Co. that addressed the takings issue in a context other than physical occupation of property was Crozier, which found that the taking of a patent right was an exercise in eminent domain.
. At issue were the data-consideration and disclosure provisions of the Federal Insecticide Fungicide, and Rodenticide Act (FIFRA), which required an applicant for pesticide registration to disclose certain trade secrets about its product. For a period of time, the statute included "an extensive measure of confidentiality” that information disclosed and designated as trade secrets would remain secret.
. Section 757 of the First Restatement of Torts specifically addressed liability for the "disclosure or use of another's trade secret.” Section 757 was omitted from the Restatement Second when cases relied less on tort principles and were moving toward a body of federal law that began to develop on trade regulation and business interference. See Introductory Note to Division 9.
. The Smith Court first looked to the plain meaning of the word “country,” and then other statutory provisions, including § 1346(b), to con-elude that Antarctica was a “country” within the meaning of the FTCA. Smith,
